Plaintiffs and defendants in Similac recall lawsuits over contaminated infant formula have agreed upon a plan which would lead to as many as five early bellwether trials.
An ingredient in the artificial sweetener Splenda may damage DNA and cause intestinal inflammation, according to a new study.
A federal judge has dismissed all Similac recall class action lawsuits, while allowing individual injury claims to proceed.
A group of state health care experts is expected to advise the CDC to add cronobacter to a national disease watch list which would require all incidents of the disease…
A CDC study calls for safer storage and preparation of infant formula products and breast pumps due to the increasing risk of cronobacter infections, such as those linked to a…
The FDA has introduced a new strategy outlining how the agency hopes to prevent cronobacter infant infections like those linked to a recent Similac recall.
An FDA advisory committee will meet next month to discuss prevention of cronobacter and other safety issues linked to powdered infant formula following a massive Similac recall.
Parties involved in Similac, Alimentum and EleCare recall lawsuits will meet in October in a status conference to discuss how to proceed with a pending motion to dismiss the individual…
An internal FDA review highlights a number of shortcomings the agency needs to address in order to prevent mishandling public health emergencies like the contaminated Similac recall in the future.
A dozen lawyers have been appointed to leadership positions in the growing litigation over recalled Abbott infant formula products.
